2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Vaginitis: new trials by email Literature Review of Vaginitis trials Research Report on Vaginitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis RIFAXIMIN VAGINAL TABLET 25 MG, RIFAXIMIN VAGINAL TABLET 100 MG, PLACEBO VAGINAL TABLET - BACTERIAL VAGINOSIS | Phase 2 | Terminated | Alfasigma S.p.A. | 392 | 2015-04-01 | 2016-10-10 |
| GoldenCareTM for the Treatment of Bacterial Vaginosis GoldenCare, Metronidazole - Bacterial Vaginosis | Phase 1 / Phase 2 | Terminated | CDA Research Group, Inc. | 8 | 2013-02-01 | 2015-02-03 |
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Infections (2) · Urogenital Diseases (2) · Vaginal Diseases (2)
Benchmarking (1) · Metronidazole (1)
Alfasigma S.p.A. (1) · CDA Research Group, Inc. (1)
United States (2)
Ashwin Chatwani, MD (1) · Raffaella Tacchi, MD (1)